Jivi, antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age …
service manual
Show more
See More
Jivi is contraindicated in patients who have a history of hypersensitivity reactions to the active substance, polyethylene glycol (PEG), mouse or hamster proteins, or other constituents of the …
service manual
Show more
See More
Jivi is an injectable medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Jivi is used to treat and control bleeding in …
service manual
Show more
See More
Jivi Mobile customer care phone number : 1800-11-7576. Jivi customer care email: [email protected]. You can visit the mentioned place even if you are looking for contact Jivi, …
Show more
See More
ЏИВИ ДОО Гевгелија е компанија основана во 1992 година, кога започна со трговија на аудио-видео опрема и апарати за домаќинство. Од самиот почеток ЏИВИ остварува …
service manual
Show more
See More
Jivi [antihemophilic factor (recombinant), PEGylated-aucl] is a sterile, nonpyrogenic, preservative-free, white to slightly yellow lyophilized powder for reconstitution with sterile Water for Injection (sWFI) as diluent for intravenous (IV) administration. The product is supplied in single-use vials containing dosage strengths of 500, 1000, 2000 an...
service manual
Show more
See More
Jivi Service centers in India. Service centers list of Jivi. You can see full address and contact information of service centers Jivi. 22,Munaga Chennaiah complex, Opp. The Lakshmi Vilas …
Show more
See More
42074 service manuals Liability Wil Manshande, nostatech en freeservicemanuals.info cannot be held responsible for any damage caused by using this website or any of the provided …
Jivi
Show more
See More
When searching for quality OEM Service Manuals or any other type of Appliance Manual, Tech Sheet or Supplement, you’ll most likely find it here at ServiceManuals.net. We have been …
Jivi
Show more
See More
Jivi is a medicine used to treat and prevent bleeding in patients with haemophilia A, an inherited bleeding disorder caused by lack of a clotting protein called factor VIII. Jivi can …
service manual
Show more
See More
Suzuki Outboard Service Repair Manual PDF Free 4-Stroke 2-Stroke , DF4 DF5 DF9.9 DF15 DT225 DT150 DT175 DT200 DT115 DT140 DF DT DF200 DF225 DF250
Jivi
Show more
See More
Sep 07, 2018 . Warm both unopened Jivi vial and prefilled diluent syringe in your hands to a comfortable temperature (do not exceed 37°C or 99°F). Remove the protective cap from the …
service manual
Show more
See More
Jivi is an injectable medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Jivi is used to treat and control bleeding in previously treated adults and adolescents (12 years of age and older) with hemophilia A.
Learn about possible savings and co-pay support for Jivi®. EHL, extended half-life; rFVIII, recombinant Factor VIII. Jivi is not indicated for use in children less than 12 years of age due to a greater risk for hypersensitivity reactions. Jivi is not indicated for use in previously untreated patients (PUPs).
Visit www.fda.gov/medwatch or call 1-800-FDA-1088. Jivi antihemophilic factor (recombinant), PEGylated-aucl, is a recombinant DNA-derived, Factor VIII concentrate indicated for use in previously treated adults and adolescents (12 years of age and older) with hemophilia A (congenital Factor VIII deficiency) for:
Your healthcare provider may also give you Jivi when you have surgery. Jivi can reduce the number of bleeding episodes in adults and adolescents with hemophilia A when used regularly (prophylaxis). Jivi is not for use in children below 12 years of age or in previously untreated patients.
Jivi is an injectable medicine used to replace clotting factor (Factor VIII or antihemophilic factor) that is missing in people with hemophilia A. Jivi is used to treat and control bleeding in previously treated adults and adolescents (12 years of age and older) with hemophilia A.
The European Medicines Agency decided that Jivi’s benefits are greater than its risks and it can be authorised for use in the EU. Studies show that Jivi is effective at preventing and treating bleeding episodes in patients with haemophilia A and its safety is comparable to that of other factor VIII products.
Developed by Bayer, it is given as an infusion into the bloodstream and also can be used on-demand in response to a bleed. How does Jivi work? Hemophilia type A is an inherited condition that results due to a mutation in the coagulation factor 8, or F8 gene.
Jivi antihemophilic factor (previously BAY 94-9027) is an approved prophylactic or preventive treatment for hemophilia type A patients, ages 12 or older. Developed by Bayer, it is given as an infusion into the bloodstream and also can be used on-demand in response to a bleed.